Literature DB >> 9178270

Molecular biology of the hexokinase isoenzyme pattern that distinguishes pathogenic Entamoeba histolytica from nonpathogenic Entamoeba dispar.

S Ortner1, C G Clark, M Binder, O Scheiner, G Wiedermann, M Duchêne.   

Abstract

The electrophoretic patterns of hexokinase and phosphoglucomutase have been widely used to distinguish Entamoeba histolytica from Entamoeba dispar isolates. Although E. histolytica and E. dispar, previously called pathogenic and nonpathogenic Entamoeba histolytica, differ clearly in sequences of many homologous genes, a conversion between the two has been reported by several laboratories, in each case showing the conversion of hexokinase (ATP, D-hexose 6-phosphotransferase, EC 2.7.1.1) isoenzyme patterns. An apparent mobility shift of this enzyme may either be due to posttranslational modification or processing, or to the appearance of a new isoform encoded by a second gene. In this study we observed that the four observed bands in the isoenzyme patterns of pathogenic and nonpathogenic forms of Entamoeba were correlated with four different cDNAs, and that the four recombinant hexokinases produced in Escherichia coli comigrated with their natural counterparts. Polymerase chain reaction (PCR) experiments did not reveal hidden genes which might be responsible for conversion phenomena. These results strongly support the redefinition of pathogenic and nonpathogenic Entamoeba histolytica as two closely related species Entamoeba histolytica and Entamoeba dispar.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9178270     DOI: 10.1016/s0166-6851(97)90008-6

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  7 in total

Review 1.  Drug targets and mechanisms of resistance in the anaerobic protozoa.

Authors:  P Upcroft; J A Upcroft
Journal:  Clin Microbiol Rev       Date:  2001-01       Impact factor: 26.132

2.  Entamoeba histolytica lectins contain unique 6-Cys or 8-Cys chitin-binding domains.

Authors:  Katrina Van Dellen; Sudip K Ghosh; Phillips W Robbins; Brendan Loftus; John Samuelson
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

3.  Comparison of the proteome profiles of Entamoeba histolytica and its close but non-pathogenic relative Entamoeba dispar.

Authors:  David Leitsch; Iain B Wilson; Katharina Paschinger; Michael Duchêne
Journal:  Wien Klin Wochenschr       Date:  2006       Impact factor: 1.704

4.  Molecular epidemiology of Entamoeba spp.: evidence of a bottleneck (Demographic sweep) and transcontinental spread of diploid parasites.

Authors:  S Ghosh; M Frisardi; L Ramirez-Avila; S Descoteaux; K Sturm-Ramirez; O A Newton-Sanchez; J I Santos-Preciado; C Ganguly; A Lohia; S Reed; J Samuelson
Journal:  J Clin Microbiol       Date:  2000-10       Impact factor: 5.948

Review 5.  Amebic infection in humans.

Authors:  Gourdas Choudhuri; Murali Rangan
Journal:  Indian J Gastroenterol       Date:  2012-08-19

6.  Characterization of a novel Entamoeba histolytica strain from Burkina Faso, Africa, possessing a unique hexokinase-2 gene.

Authors:  J Suzuki; S Kobayashi; M Imada; M E Tolba; T Takeuchi
Journal:  Parasite       Date:  2011-11       Impact factor: 3.000

7.  Choke point analysis of metabolic pathways in E.histolytica: a computational approach for drug target identification.

Authors:  Shailza Singh; Balwant Kishen Malik; Durlabh Kumar Sharma
Journal:  Bioinformation       Date:  2007-10-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.